|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,056 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,125,160 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
786,589 |
|
|
Total
Value |
$65,064,010 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 30 of 34
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INCY |
Incyte Corp |
Director |
|
2020-09-30 |
4 |
A |
$89.74 |
$22,794 |
D/D |
254 |
9,444 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-02-08 |
4 |
AS |
$89.77 |
$1,346,550 |
D/D |
(15,000) |
419,602 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-01-09 |
4 |
AS |
$89.79 |
$359,160 |
D/D |
(4,000) |
170,682 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-01-11 |
4 |
AS |
$89.84 |
$359,360 |
D/D |
(4,000) |
170,682 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-12-28 |
4 |
AS |
$89.89 |
$898,912 |
D/D |
(10,000) |
225,894 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-10-14 |
4 |
AS |
$89.89 |
$359,560 |
D/D |
(4,000) |
324,324 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-11-25 |
4 |
AS |
$90.00 |
$180,000 |
I/I |
(2,000) |
43,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-06-03 |
4 |
D |
$90.00 |
$597,600 |
D/D |
(6,640) |
378,584 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-02-21 |
4 |
AS |
$90.12 |
$270,360 |
D/D |
(3,000) |
288,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-03-09 |
4 |
AS |
$90.18 |
$541,080 |
D/D |
(6,000) |
206,364 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-01-05 |
4 |
AS |
$90.32 |
$903,203 |
D/D |
(10,000) |
225,894 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-02-27 |
4 |
S |
$90.35 |
$90,350 |
D/D |
(1,000) |
562,203 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-03-13 |
4 |
AS |
$90.45 |
$723,600 |
D/D |
(8,000) |
487,856 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-01-10 |
4 |
AS |
$90.55 |
$271,650 |
D/D |
(3,000) |
288,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-06-05 |
4 |
AS |
$90.56 |
$452,800 |
D/D |
(5,000) |
226,924 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-06-02 |
4 |
D |
$90.72 |
$602,381 |
D/D |
(6,640) |
226,924 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-03-07 |
4 |
AS |
$90.78 |
$363,120 |
D/D |
(4,000) |
328,701 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-11-16 |
4 |
AS |
$90.97 |
$3,790,795 |
D/D |
(41,670) |
323,368 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-04-11 |
4 |
AS |
$90.99 |
$1,819,800 |
D/D |
(20,000) |
474,994 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-03-10 |
4 |
AS |
$91.09 |
$455,450 |
D/D |
(5,000) |
206,364 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-01-08 |
4 |
AS |
$91.14 |
$549,523 |
D/D |
(6,000) |
288,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-04-12 |
4 |
AS |
$91.26 |
$1,825,200 |
D/D |
(20,000) |
474,994 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-04-08 |
4 |
AS |
$91.27 |
$275,598 |
D/D |
(3,000) |
324,211 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-01-10 |
4 |
AS |
$91.31 |
$365,240 |
D/D |
(4,000) |
170,682 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-03-15 |
4 |
AS |
$91.42 |
$457,100 |
D/D |
(5,000) |
206,364 |
0 |
- |
|
850 Records found
|
|
Page 30 of 34 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|